{"id":"inhaled-mannitol","safety":{"commonSideEffects":[{"rate":null,"effect":"Cough"},{"rate":null,"effect":"Throat irritation"},{"rate":null,"effect":"Bronchospasm"},{"rate":null,"effect":"Wheezing"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mannitol is a sugar alcohol that, when inhaled as a dry powder, creates an osmotic gradient in the airway lumen. This draws water into the airway surface liquid, hydrating thick mucus and improving its clearance by cilia. The mechanism is thought to reduce airway inflammation and improve lung function in conditions characterized by dehydrated secretions.","oneSentence":"Inhaled mannitol acts as an osmotic agent that draws fluid into the airways to hydrate secretions and improve mucociliary clearance.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:15.144Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cystic fibrosis"},{"name":"Bronchiectasis"}]},"trialDetails":[{"nctId":"NCT06473779","phase":"PHASE3","title":"Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Severe Asthma","enrollment":326},{"nctId":"NCT05555290","phase":"PHASE3","title":"PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-09-28","conditions":"Asthma","enrollment":190},{"nctId":"NCT05740618","phase":"PHASE4","title":"Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-03-28","conditions":"Cystic Fibrosis","enrollment":14},{"nctId":"NCT06897761","phase":"NA","title":"Development of an Interactive Digital Respiratory Game and Device and Investigation of Its Effectiveness in Children With Bronchiectasis","status":"RECRUITING","sponsor":"Atlas University","startDate":"2025-10-07","conditions":"Bronchiectasis","enrollment":40},{"nctId":"NCT06876064","phase":"","title":"National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2025-10","conditions":"Rheumatoid Arthritis (RA)","enrollment":150},{"nctId":"NCT03105843","phase":"PHASE4","title":"Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol","status":"RECRUITING","sponsor":"Dr. Diane Lougheed","startDate":"2022-03-01","conditions":"Asthma, Cough, Cough Variant Asthma","enrollment":30},{"nctId":"NCT05034367","phase":"NA","title":"Reference Ranges for the Cough Responsiveness to Inhaled Mannitol","status":"COMPLETED","sponsor":"Kuopio University Hospital","startDate":"2022-01-17","conditions":"Cough","enrollment":132},{"nctId":"NCT06105671","phase":"NA","title":"U-LABA/ICS Effects on Exercise Performance, Formoterol","status":"COMPLETED","sponsor":"Morten Hostrup, PhD","startDate":"2024-01-05","conditions":"Exercise Performance","enrollment":20},{"nctId":"NCT00446121","phase":"","title":"Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2010-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":""},{"nctId":"NCT04842331","phase":"PHASE2, PHASE3","title":"PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)","status":"WITHDRAWN","sponsor":"Thirty Respiratory Limited","startDate":"2021-09","conditions":"Respiratory Viral Infection, Respiratory Tract Diseases, COVID-19 Respiratory Infection","enrollment":""},{"nctId":"NCT05351086","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults","status":"COMPLETED","sponsor":"Pulmatrix Inc.","startDate":"2022-06-09","conditions":"Healthy","enrollment":26},{"nctId":"NCT04565847","phase":"PHASE2","title":"The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls","status":"COMPLETED","sponsor":"McMaster University","startDate":"2020-11-30","conditions":"Cough","enrollment":20},{"nctId":"NCT03825302","phase":"","title":"Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2021-12-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT01064245","phase":"NA","title":"Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests","status":"COMPLETED","sponsor":"Dr. Diane Lougheed","startDate":"2010-02-01","conditions":"Asthma, Cough Variant Asthma","enrollment":29},{"nctId":"NCT03509259","phase":"","title":"Cardiovascular Diseases in Elderly Asthma","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2019-03-21","conditions":"Asthma","enrollment":72},{"nctId":"NCT02630511","phase":"NA","title":"Asthma Exacerbations and Vascular Function","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2015-12","conditions":"Asthma","enrollment":52},{"nctId":"NCT02134353","phase":"PHASE3","title":"A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects","status":"COMPLETED","sponsor":"Syntara","startDate":"2014-09","conditions":"Cystic Fibrosis","enrollment":423},{"nctId":"NCT00630812","phase":"PHASE3","title":"Long Term Administration of Inhaled Mannitol in Cystic Fibrosis","status":"COMPLETED","sponsor":"Syntara","startDate":"2008-09","conditions":"Cystic Fibrosis","enrollment":318},{"nctId":"NCT02991781","phase":"NA","title":"Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2017-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Asthma, Smoking","enrollment":106},{"nctId":"NCT03620422","phase":"NA","title":"Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-01-11","conditions":"Asthma, Cough","enrollment":40},{"nctId":"NCT00860938","phase":"PHASE4","title":"Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD","status":"COMPLETED","sponsor":"Cantonal Hosptal, Baselland","startDate":"2007-04","conditions":"COPD","enrollment":90},{"nctId":"NCT03505489","phase":"PHASE3","title":"The Effect of Deep Inhalation on Mannitol Responsiveness","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2018-06-01","conditions":"Asthma","enrollment":26},{"nctId":"NCT03575663","phase":"","title":"The Asthma Bronchial Challenge Study","status":"COMPLETED","sponsor":"University of East Anglia","startDate":"2018-04-25","conditions":"Asthma","enrollment":46},{"nctId":"NCT02039011","phase":"PHASE4","title":"Ultra-long Acting Bronchodilator Therapy in Asthmatics","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2014-02","conditions":"Asthma","enrollment":14},{"nctId":"NCT03639727","phase":"NA","title":"Cough in Eastern and Central Finland","status":"COMPLETED","sponsor":"Kuopio University Hospital","startDate":"2018-09-01","conditions":"Chronic Cough","enrollment":61},{"nctId":"NCT01887197","phase":"PHASE1","title":"Repeatability and Response Study of Absorptive Clearance Scans","status":"COMPLETED","sponsor":"Tim Corcoran","startDate":"2013-06","conditions":"Cystic Fibrosis","enrollment":24},{"nctId":"NCT02306473","phase":"EARLY_PHASE1","title":"The Leaky Lung Test","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2015-10","conditions":"Asthma, Allergy, Reactive Airway Disease","enrollment":100},{"nctId":"NCT01725360","phase":"PHASE4","title":"Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma","status":"COMPLETED","sponsor":"Cantonal Hosptal, Baselland","startDate":"2007-01","conditions":"Asthma","enrollment":17},{"nctId":"NCT01642745","phase":"PHASE4","title":"Mannitol (Aridol) and Methacholine (Provocholine) Responsiveness","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2011-11","conditions":"Asthma","enrollment":20},{"nctId":"NCT00446667","phase":"PHASE1, PHASE2","title":"A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD","status":"WITHDRAWN","sponsor":"Syntara","startDate":"2006-10","conditions":"COPD, Exacerbation","enrollment":""},{"nctId":"NCT00669331","phase":"PHASE3","title":"Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis","status":"COMPLETED","sponsor":"Syntara","startDate":"2009-11","conditions":"Bronchiectasis","enrollment":485},{"nctId":"NCT00117182","phase":"PHASE2","title":"Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD","status":"COMPLETED","sponsor":"Syntara","startDate":"2005-07","conditions":"Lung Diseases, Obstructive","enrollment":140},{"nctId":"NCT01883531","phase":"PHASE2","title":"Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years","status":"COMPLETED","sponsor":"Syntara","startDate":"2013-06","conditions":"Cystic Fibrosis","enrollment":95},{"nctId":"NCT02104284","phase":"NA","title":"A Comparative Bronchial Provocation Study With Mannitol and Methacolinie in a Korean Population","status":"COMPLETED","sponsor":"BL&H Co., Ltd","startDate":"2011-07","conditions":"Asthma","enrollment":104},{"nctId":"NCT00491153","phase":"","title":"Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist Pulmonologist","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2007-09","conditions":"Asthma","enrollment":35},{"nctId":"NCT01427192","phase":"PHASE2","title":"Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2010-11","conditions":"Pulmonary Hypertension, Breathing-Related Sleep Disorder","enrollment":23},{"nctId":"NCT00526357","phase":"PHASE2","title":"Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma","status":"COMPLETED","sponsor":"Firestone Institute for Respiratory Health","startDate":"2007-08","conditions":"Asthma","enrollment":24},{"nctId":"NCT00916526","phase":"NA","title":"Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2008-11","conditions":"Cough, Bronchial Hyperreactivity","enrollment":30},{"nctId":"NCT01216579","phase":"NA","title":"Steroid Titration Against Mannitol IN Asthma","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2004-03","conditions":"Asthma","enrollment":164},{"nctId":"NCT00446680","phase":"PHASE3","title":"Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study","status":"COMPLETED","sponsor":"Syntara","startDate":"2007-03","conditions":"Cystic Fibrosis","enrollment":340},{"nctId":"NCT01076491","phase":"PHASE1, PHASE2","title":"High Dose Inhaled Mannitol Study","status":"COMPLETED","sponsor":"Syntara","startDate":"2009-01","conditions":"Bronchiectasis","enrollment":10},{"nctId":"NCT00455130","phase":"PHASE2","title":"A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis","status":"COMPLETED","sponsor":"Syntara","startDate":"2004-03","conditions":"Cystic Fibrosis","enrollment":""},{"nctId":"NCT00792714","phase":"PHASE1","title":"Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients","status":"COMPLETED","sponsor":"Syntara","startDate":"2008-12","conditions":"Cystic Fibrosis","enrollment":18},{"nctId":"NCT00117208","phase":"PHASE2","title":"Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis","status":"COMPLETED","sponsor":"Syntara","startDate":"2005-11","conditions":"Cystic Fibrosis","enrollment":20},{"nctId":"NCT00730977","phase":"PHASE1, PHASE2","title":"A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device","status":"COMPLETED","sponsor":"Syntara","startDate":"2008-08","conditions":"Healthy, Bronchiectasis","enrollment":15},{"nctId":"NCT00446771","phase":"PHASE1","title":"A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects","status":"COMPLETED","sponsor":"Syntara","startDate":"2006-10","conditions":"Healthy Volunteers","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":101,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mannitol","IDPM","Dry Powder Mannitol for Inhalation","Bronchitol"],"phase":"phase_3","status":"active","brandName":"Inhaled mannitol","genericName":"Inhaled mannitol","companyName":"Syntara","companyId":"syntara","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhaled mannitol acts as an osmotic agent that draws fluid into the airways to hydrate secretions and improve mucociliary clearance. Used for Cystic fibrosis, Bronchiectasis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}